MicroRNAs (
miRNAs) have been suggested to repress transcription via binding the 3'-untranslated regions of mRNAs. However, the involvement and details of
miRNA-mediated epigenetic regulation, particularly in targeting genomic
DNA and mediating epigenetic regulation, remain largely uninvestigated. In the present study,
transcription factor CCAAT/enhancer binding protein delta (CEBPD) was responsive to the anticancer
drug bortezomib, a clinical and highly selective
drug for
leukemia treatment, and contributed to
bortezomib-induced cell death. Interestingly, following the identification of CEBPD-induced
miRNAs, we found that miR-744, miR-3154 and miR-3162 could target CpG islands in the 5'-flanking region of the CEBPD gene. We previously demonstrated that the Yin Yang 1 (YY1)/polycomb group (PcG)
protein/
DNA methyltransferase (DNMT) complex is important for
CCAAT/enhancer binding protein delta (CEBPD) gene inactivation; we further found that Argonaute 2 (Ago2) interacts with YY1 and binds to the CEBPD promoter. The
miRNA/Ago2/YY1/PcG group
protein/DNMT complex linked the inactivation of CEBPD and genes adjacent to its 5'-flanking region, including
protein kinase DNA-activated catalytic
polypeptide (PRKDC), minichromosome maintenance-deficient 4 (MCM4) and
ubiquitin-conjugating enzyme E2 variant 2 (UBE2V2), upon
bortezomib treatment. Moreover, we revealed that
miRNA binding is necessary for YY1/PcG group
protein/DNMT complex-mediated epigenetic gene silencing and is associated with
bortezomib-induced methylation on genomic
DNA. The present study successfully characterized the interactions of the
miRNA/Ago2/YY1/PcG group
protein/DNMT complex and provided new insights for
miRNA-mediated epigenetic regulation in
bortezomib-induced leukemic cell arrest and cell death.